Faculty
-
August 13, 2014
On ABC News, Robert Klitzman Explores the Ethics of New Ebola Treatment
Although the World Health Organization has approved the new, experimental Ebola medication ZMapp, the limited supply of the drug raises questions about which patients should be prioritized for treatment.
ABC News said, "ZMapp...has notably not been supplied to the Africans who make up the majority of victims."
Bioethics director Robert Klitzman commented, "We want to make sure that we have clear criteria to make sure that it's done fairly."
Faculty
From Silicon Valley Bank to Lehman Brothers, history shows that liquidity crises are often driven less by balance sheet metrics and more by confidence. In Columbia’s M.S. in Enterprise Risk Management program, students learn to assess both the quantitative and behavioral dimensions of liquidity risk.
Faculty
M.S. in Applied Analytics Professor Siddhartha Dalal traces his decades-long career in using AI to save lives.
Faculty
Accelerating electric vehicle adoption depends on advances in EV technology, public policies, and infrastructure investments.
All News
